Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data

Abstract Background Predicting the drug response of a patient is important for precision oncology. In recent studies, multi-omics data have been used to improve the prediction accuracy of drug response. Although multi-omics data are good resources for drug response prediction, the large dimension of...

Full description

Bibliographic Details
Main Authors: Sejin Park, Jihee Soh, Hyunju Lee
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Bioinformatics
Subjects:
Online Access:https://doi.org/10.1186/s12859-021-04146-z
_version_ 1819047331966746624
author Sejin Park
Jihee Soh
Hyunju Lee
author_facet Sejin Park
Jihee Soh
Hyunju Lee
author_sort Sejin Park
collection DOAJ
description Abstract Background Predicting the drug response of a patient is important for precision oncology. In recent studies, multi-omics data have been used to improve the prediction accuracy of drug response. Although multi-omics data are good resources for drug response prediction, the large dimension of data tends to hinder performance improvement. In this study, we aimed to develop a new method, which can effectively reduce the large dimension of data, based on the supervised deep learning model for predicting drug response. Results We proposed a novel method called Supervised Feature Extraction Learning using Triplet loss (Super.FELT) for drug response prediction. Super.FELT consists of three stages, namely, feature selection, feature encoding using a supervised method, and binary classification of drug response (sensitive or resistant). We used multi-omics data including mutation, copy number aberration, and gene expression, and these were obtained from cell lines [Genomics of Drug Sensitivity in Cancer (GDSC), Cancer Cell Line Encyclopedia (CCLE), and Cancer Therapeutics Response Portal (CTRP)], patient-derived tumor xenografts (PDX), and The Cancer Genome Atlas (TCGA). GDSC was used for training and cross-validation tests, and CCLE, CTRP, PDX, and TCGA were used for external validation. We performed ablation studies for the three stages and verified that the use of multi-omics data guarantees better performance of drug response prediction. Our results verified that Super.FELT outperformed the other methods at external validation on PDX and TCGA and was good at cross-validation on GDSC and external validation on CCLE and CTRP. In addition, through our experiments, we confirmed that using multi-omics data is useful for external non-cell line data. Conclusion By separating the three stages, Super.FELT achieved better performance than the other methods. Through our results, we found that it is important to train encoders and a classifier independently, especially for external test on PDX and TCGA. Moreover, although gene expression is the most powerful data on cell line data, multi-omics promises better performance for external validation on non-cell line data than gene expression data. Source codes of Super.FELT are available at  https://github.com/DMCB-GIST/Super.FELT .
first_indexed 2024-12-21T10:58:40Z
format Article
id doaj.art-deb7d559623d436d8dea879f775a090e
institution Directory Open Access Journal
issn 1471-2105
language English
last_indexed 2024-12-21T10:58:40Z
publishDate 2021-05-01
publisher BMC
record_format Article
series BMC Bioinformatics
spelling doaj.art-deb7d559623d436d8dea879f775a090e2022-12-21T19:06:25ZengBMCBMC Bioinformatics1471-21052021-05-0122112310.1186/s12859-021-04146-zSuper.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics dataSejin Park0Jihee Soh1Hyunju Lee2School of Electrical Engineering and Computer Science, Gwangju Institute of Science and TechnologySchool of Electrical Engineering and Computer Science, Gwangju Institute of Science and TechnologySchool of Electrical Engineering and Computer Science, Gwangju Institute of Science and TechnologyAbstract Background Predicting the drug response of a patient is important for precision oncology. In recent studies, multi-omics data have been used to improve the prediction accuracy of drug response. Although multi-omics data are good resources for drug response prediction, the large dimension of data tends to hinder performance improvement. In this study, we aimed to develop a new method, which can effectively reduce the large dimension of data, based on the supervised deep learning model for predicting drug response. Results We proposed a novel method called Supervised Feature Extraction Learning using Triplet loss (Super.FELT) for drug response prediction. Super.FELT consists of three stages, namely, feature selection, feature encoding using a supervised method, and binary classification of drug response (sensitive or resistant). We used multi-omics data including mutation, copy number aberration, and gene expression, and these were obtained from cell lines [Genomics of Drug Sensitivity in Cancer (GDSC), Cancer Cell Line Encyclopedia (CCLE), and Cancer Therapeutics Response Portal (CTRP)], patient-derived tumor xenografts (PDX), and The Cancer Genome Atlas (TCGA). GDSC was used for training and cross-validation tests, and CCLE, CTRP, PDX, and TCGA were used for external validation. We performed ablation studies for the three stages and verified that the use of multi-omics data guarantees better performance of drug response prediction. Our results verified that Super.FELT outperformed the other methods at external validation on PDX and TCGA and was good at cross-validation on GDSC and external validation on CCLE and CTRP. In addition, through our experiments, we confirmed that using multi-omics data is useful for external non-cell line data. Conclusion By separating the three stages, Super.FELT achieved better performance than the other methods. Through our results, we found that it is important to train encoders and a classifier independently, especially for external test on PDX and TCGA. Moreover, although gene expression is the most powerful data on cell line data, multi-omics promises better performance for external validation on non-cell line data than gene expression data. Source codes of Super.FELT are available at  https://github.com/DMCB-GIST/Super.FELT .https://doi.org/10.1186/s12859-021-04146-zPrecision oncologyMulti-omics dataDrug response predictionencoder using supervised methodsTriplet lossPharmacogenomics
spellingShingle Sejin Park
Jihee Soh
Hyunju Lee
Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data
BMC Bioinformatics
Precision oncology
Multi-omics data
Drug response prediction
encoder using supervised methods
Triplet loss
Pharmacogenomics
title Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data
title_full Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data
title_fullStr Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data
title_full_unstemmed Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data
title_short Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data
title_sort super felt supervised feature extraction learning using triplet loss for drug response prediction with multi omics data
topic Precision oncology
Multi-omics data
Drug response prediction
encoder using supervised methods
Triplet loss
Pharmacogenomics
url https://doi.org/10.1186/s12859-021-04146-z
work_keys_str_mv AT sejinpark superfeltsupervisedfeatureextractionlearningusingtripletlossfordrugresponsepredictionwithmultiomicsdata
AT jiheesoh superfeltsupervisedfeatureextractionlearningusingtripletlossfordrugresponsepredictionwithmultiomicsdata
AT hyunjulee superfeltsupervisedfeatureextractionlearningusingtripletlossfordrugresponsepredictionwithmultiomicsdata